Research Article
Factors Affecting ICU Stay and Length of Stay in the ICU in Patients with HELLP Syndrome in a Tertiary Referral Hospital
Table 1
Evaluation of demographic and laboratory findings in the patients with HELLP syndrome.
| | | n | Percent (%) |
| Parity | Nulliparous | 168 | 49.1 | Multiparous | 174 | 50.9 |
| Gestational age at delivery (week) | 0–22 | 18 | 5.3 | 23–27 | 56 | 16.3 | 28–36 | 210 | 61.4 | 37–40 | 58 | 17 |
| Mode of delivery | Normal vaginal delivery | 56 | 16.3 | Cesarean section | 286 | 83.7 |
| Hypertension | Yes | 307 | 89.8 | No | 35 | 10.2 |
| Thrombocytopenia | Yes | 295 | 86.3 | No | 47 | 13.7 |
| Anemia | Yes | 50 | 14.6 | No | 292 | 85.4 |
| Proteinuria | +1 (75 mg) | 98 | 28.6 | +2 (150 mg) | 160 | 46.7 | +3 (500 mg) | 49 | 14.3 | No | 35 | 10.2 |
| Mississippi classification | Class 1 | 50 | 14.6 | Class 2 | 164 | 48.0 | Class 3 | 128 | 37.4 |
| Maternal complication | ARF | 8 | 2.3 | GIB | 1 | 0.3 | PRESS | 10 | 2.9 | DIC | 4 | 1.1 | Sepsis | 2 | 0.6 | Postpartum cardiomyopathy | 1 | 0.3 | SAB | 2 | 0.6 | Total | 28 | 8.1 |
| Blood transfusion | Yes | 93 | 27.2 | No | 249 | 72.8 |
| Type of blood transfusion | Fresh frozen plasma (cc) | 43 | 24.3 | Erythrocyte suspension (cc) | 59 | 33.3 | Random suspension (cc) | 18 | 10.2 | Apheresis platelet suspension (cc) | 57 | 32.2 |
| Dexamethasone treatment | Yes | 252 | 73.6 | No | 90 | 26.4 | Reason of relaparotomy | Intraabdominal major bleeding | 2 | 0.6 |
| Postpartum HELLP | Yes | 84 | 24.6 | No | 258 | 75.4 |
| Place of birth | Delivery outside of the center | 65 | 19 | Delivery in the center | 277 | 81 |
| Multiple pregnancy | Yes | 10 | 2.9 | No | 342 | 97.1 |
| Maternal mortality | Yes | 2 | 0.6 | No | 340 | 99.4 |
| Newborn mortality | Yes | 18 | 5.2 | No | 324 | 94.8 |
|
|
Data are presented as percent. ARF: acute renal failure, GIB: gastrointestinal bleeding, PRESS: posterior reversible encephalopathy syndrome, DIC: disseminated intravascular coagulation, SAB: subarachnoid bleeding.
|